NF-κB p105/p50: Generation, Regulatory Mechanisms, and Roles in the NF-κB Signaling Pathway

1. Concept

The nuclear factor-kappa B (NF-κB) signaling pathway is an evolutionarily conserved transcriptional regulatory network阿 serving as a central hub for cellular responses to stress, inflammation, and pathogens. In mammals, the NF-κB family includes five members, with NF-κB1 (p105/p50) being a key component. p105 acts as a precursor protein that undergoes tightly regulated processing to generate the mature p50 subunit. Both p105 and p50 contain a conserved Rel homology domain (RHD) for DNA binding and dimerization, while p105’s C-terminal IκB-like domain enables it to function as a "molecular sponge" that sequesters other NF-κB subunits. p50 forms homodimers (typically transcriptionally repressive) or heterodimers (e.g., with p65) to regulate target gene expression, playing critical roles in immune responses, inflammation, cell survival, and tumorigenesis.

2. Research Frontiers

Recent advances have deepened our understanding of p105/p50’s generation and regulatory mechanisms. The processing of p105 into p50 involves co-translational and signal-induced post-translational pathways, with phosphorylation (e.g., Ser337, Ser932) and ubiquitination as key regulatory events. Phosphorylation at Ser337—catalyzed by kinases like IKK and CKII—modulates p50’s transcriptional activity by influencing DNA binding or interactions with co-factors. In the canonical NF-κB pathway, IKKβ-mediated degradation of IκB proteins releases p50/p65 heterodimers, while the non-canonical pathway involves NIK/IKKα-driven processing of p100 into p52.

Cutting-edge research uses p105/p50-specific antibodies to track processing dynamics, clarify subcellular localization, and distinguish pathway contributions. Studies link aberrant p105/p50 regulation to cancer, autoimmune diseases, and chronic inflammation, highlighting its potential as a therapeutic target. Future directions focus on dissecting the crosstalk between phosphorylation events and the role of p50 in tumor microenvironment remodeling.

3. Research Significance

p105/p50 research holds profound significance in immunology and disease biology. As a core component of the NF-κB pathway, p105’s dual role as a precursor and inhibitory molecule provides precise control over signal output—buffering excessive activation and ensuring context-specific responses. The mature p50 subunit is indispensable for mounting effective immune and inflammatory responses, while its dysregulation drives pathological processes.

Understanding p105 processing and p50 function unlocks insights into disease mechanisms: for example, abnormal p50 activation promotes tumor cell proliferation and immune evasion, while defective p50 signaling impairs host defense. This research bridges basic signaling biology and clinical translation, offering new targets for treating NF-κB-related diseases. Additionally, p105/p50 phosphorylation (e.g., Ser337) serves as a potential biomarker for pathway activation and therapeutic response.

4. Related Mechanisms, Research Methods, and Product Applications

Mechanisms

p105/p50 exerts its regulatory effects through conserved and context-dependent mechanisms:

• p105 Processing: p105 is converted to p50 via co-translational cleavage or signal-induced post-translational processing. Phosphorylation at Ser337 modulates p50’s transcriptional activity, while Ser932 phosphorylation regulates C-terminal degradation.
• Canonical Pathway Activation: Pro-inflammatory signals (TNF-α, LPS) activate the IKK complex, leading to IκB degradation and nuclear translocation of p50/p65 heterodimers, which drive target gene expression.
• Transcriptional Regulation: p50 homodimers repress transcription by occupying κB sites, while heterodimers with p65 or RelB activate gene expression, balancing pro-inflammatory and anti-inflammatory responses.

Research Methods and Product Applications

ANT BIO PTE. LTD.’s high-quality phospho-specific antibody (under the Starter sub-brand) is an indispensable tool for p105/p50 research:

Product: Phospho-NF-κB p105/p50 (Ser337) Recombinant Rabbit mAb (S0B1233)

• Processing Dynamics Tracking: Detects Ser337-phosphorylated p105/p50 via Western Blot (WB) or immunofluorescence (IF), enabling monitoring of processing efficiency under different stimuli.
• Functional Regulation Studies: Investigates how Ser337 phosphorylation modulates p50’s transcriptional activity, including interactions with DNA, co-activators, or repressors.
• Pathway Differentiation: Simultaneously detects p105/p50 and p100/p52 to distinguish canonical vs. non-canonical pathway contributions in complex biological systems.
• Disease Research: Analyzes aberrant p105/p50 phosphorylation in disease models or clinical samples, uncovering mechanisms of NF-κB dysregulation in cancer, inflammation, or autoimmune disorders.

5. Brand Mission

ANT BIO PTE. LTD. is dedicated to empowering the global life science community with innovative, high-quality reagents and solutions to accelerate scientific discovery and improve human health. We specialize in providing antibodies, recombinant proteins, ELISA kits, and general life science reagents through three dedicated sub-brands: Absin (general reagents and kits), Starter (antibodies), and UA (recombinant proteins). Backed by advanced development platforms—including recombinant monoclonal antibody platforms, multi-system recombinant protein expression (E.coli, CHO, HEK293, Insect Cells), One-Step ELISA Platform, and PTM Pan-Modification Antibody Platform—we adhere to stringent international certifications (EU 98/79/EC, ISO9001, ISO13485). Our mission is to be a trusted partner for researchers worldwide, delivering reliable products and tailored services that drive breakthroughs in signal transduction, immunology, and disease therapeutics.

6. Related Product List

7. AI Disclaimer

This article is AI-compiled and interpreted based on the original work. All intellectual property (e.g., images, data) of the original publication shall belong to the journal and the research team. For any infringement, please contact us promptly and we will take immediate action.

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.